My Alcon | United Kingdom

This page is available in English. Select below for other countries.

Select Another Country


A flexible lens-wearing experience designed for up to 30 nights of continuous wear1†


AIR OPTIX NIGHT and DAY pack shot

AIR OPTIX™ NIGHT & DAY™ AQUA can help patients with SmartShield® Technology and great breathability2*


AIR OPTIX™ NIGHT & DAY™ AQUA contact lenses are approved for up to 30 days and nights of continuous wear.1†

Smartshield technology
Smartshield technology

SmartShield® Technology

Delivers a protective layer of moisture to help shield lenses from irritating deposits3-5

high breathability
high breathability

Highest Breathability2,6*

Oxygen continuously flows through the lens for white, healthy looking eyes2


A Winning Combination

For your patients who want to wake up to clear, comfortable vision.

*Dk/t = 175 @ -3.00D. Other factors may impact eye health.

AIR OPTIX™ NIGHT & DAY™ AQUA offers overall deposit resistance and wettability that outperforms other lenses


Superior Lipid Deposit Resistance4,5


Lenses worn daily through manufacturer-recommended replacement period. AOSEPT™ PLUS with HydraGlyde™ Cleaning & Disinfecting Solution used for cleaning and disinfection. Median values represented.


lipid deposit chart

The most breathable lens material on the market6


oxygen profile chart AONDA

AIR OPTIX™ NIGHT & DAY™ AQUA is made from lotrafilcon A which was shown to have a low rate of microbial keratitis (MK)7


A rigorous post-market surveillance study of nearly 5,000 lotrafilcon A contact lens wearers for one year, and across 100+ clinical practices showed:

out of 10000 people

For those who were able to continuously wear the lenses ≥3 weeks, there was a lower rate of presumed MK than for those with <3 weeks of wear (p=0.02).

*Based on calucalted overall annual rate of MK


To help your patients get the most from their contact lenses, recommend AOSEPT™ PLUS with HydraGlyde™ or OPTI-FREE® Puremoist®

Contact lens solutions

AIR OPTIX™ NIGHT & DAY™ AQUA Technical Specifications

AIR OPTIX NIGHT and DAY parameters
AIR OPTIX plus HydgraGlyde MULTIFOCAL contact lens pro teaser
AIR OPTIX plus HydgraGlyde MULTIFOCAL contact lens pro teaser

AIR OPTIX™ plus HydraGlyde™ Multifocal


A multifocal contact lens designed to provide outstanding comfort from day 1 to day 30.8-10*

AIR OPTIX plus HydraGlyde Toric contact lens pack
AIR OPTIX plus HydraGlyde Toric contact lens pack

AIR OPTIX™ plus HydraGlyde™ for Astigmatism


Outstanding stability with a predictable fit, and outstanding comfort from day 1 to day 30 for your astigmatic patients.8-11*


*Based on clinical studies with AIR OPTIX™ AQUA lenses.

^Trademarks are the property of their respective owners
Extended wear for up to 30 continuous nights, as prescribed by an eye care professional.



1. AIR OPTIX™ NIGHT & DAY™ AQUA package insert.

2. Based on the ratio of lens oxygen transmissibilities; Alcon data on file, 2009, 2010.

3. Alcon data on file, 2008.

4. Nash W, Gabriel M, Mowrey-McKee M. A comparison of various silicone hydrogel lenses; lipid and protein deposition as a result of daily wear. Optom Vis Sci. 2010;87: E-abstract 105110.

5. Nash WL, Gabriel MM. Ex vivo analysis of cholesterol deposition for commercially available silicone hydrogel contact lenses using a fluorometric enzymatic assay. Eye Contact Lens. 2014;40(5):277-282.

6. Based on published manufacturer-provided DK/T values in Tylers Quarterly, 2021.

7. Schein O, McNally J, Katz J, Chalmers R. The incidence of microbial keratitis among wearers of a 30-day silicone hydrogel extended-wear contact lens. Ophthalmology. 2005;112(12):2172-79.

8. Eiden SB, Davis R, Bergenske P. Prospective study of lotrafilcon B lenses comparing 2 vrsus 4 weeks of wear for objective and subjective measures of health, comfort, and vision. Eye Contact Lens. 2013;39(4):290-294.

9. Lemp J, Kern J. A comparison of real time and recall comfort assessments. Optom Vis Sci. 2016;93:E-abstract 165256.

10. Based on a 30-day clinical study of 75 habitual lotrafilcon B lens wearers; Alcon data on file, 2017.

11. In a randomized, subject-masked, multi-site clinical study with over 150 patients; significance demonstrated at the 0.05 level, Alcon data on file, 2005.


See instructions for use for wear, care, precautions, warnings, contraindications and adverse effects.